The European Union will seek to thrash out an agreement on sweeping rules to regulate artificial intelligence on Wednesday, following months of difficult negotiations in particular on how to monitor generative AI applications like ChatGPT.
ChatGPT wowed with its ability to produce poems and essays within seconds from simple user prompts.
AI proponents say the technology will benefit humanity, transforming everything from work to health care, but others worry about the risks it poses to society, fearing it could thrust the world into unprecedented chaos.
Brussels is bent on bringing big tech to heel with a powerful legal armory to protect EU citizens’ rights, especially those covering privacy and data protection.
The European Commission, the EU’s executive arm, first proposed an AI law in 2021 that would regulate systems based on the level of risk they posed. For example, the greater the risk to citizens’ rights or health, the greater the systems’ obligations.
Negotiations on the final legal text began in June, but a fierce debate in recent weeks over how to regulate general-purpose AI like ChatGPT and Google’s Bard chatbot threatened talks at the last minute.
Negotiators from the European Parliament and EU member states began discussions on Wednesday and the talks were expected to last into the evening.
Some member states worry that too much regulation will stifle innovation and hurt the chances of producing European AI giants to challenge those in the United States, including ChatGPT’s creator OpenAI as well as tech titans like Google and Meta.
Although there is no real deadline, senior EU figures have repeatedly said the bloc must finalize the law before the end of 2023.
Chasing local champions
EU diplomats, industry sources and other EU officials have warned the talks could end without an agreement as stumbling blocks remain over key issues.
Others have suggested that even if there is a political agreement, several meetings will still be needed to hammer out the law’s technical details.
And should EU negotiators reach agreement, the law would not come into force until 2026 at the earliest.
The main sticking point is over how to regulate so-called foundation models—designed to perform a variety of tasks—with France, Germany and Italy calling to exclude them from the tougher parts of the law.
“France, Italy and Germany don’t want a regulation for these models,” said German MEP Axel Voss, who is a member of the special parliamentary committee on AI.
The parliament, however, believes it is “necessary… for transparency” to regulate such models, Voss said.
Late last month, the three biggest EU economies published a paper calling for an “innovation-friendly” approach for the law known as the AI Act.
Berlin, Paris and Rome do not want the law to include restrictive rules for foundation models, but instead say they should adhere to codes of conduct.
Many believe this change in view is motivated by their wish to avoid hindering the development of European champions—and perhaps to help companies such as France’s Mistral AI and Germany’s Aleph Alpha.
Another sticking point is remote biometric surveillance—basically, facial identification through camera data in public places.
The EU parliament wants a full ban on “real time” remote biometric identification systems, which member states oppose. The commission had initially proposed that there could be exemptions to find potential victims of crime including missing children.
There have been suggestions MEPs could concede on this point in exchange for concessions in other areas.
Brando Benifei, one of the MEPs leading negotiations for the parliament, said he saw a “willingness” by everyone to conclude talks.
But, he added, “we are not scared of walking away from a bad deal”.
France’s digital minister Jean-Noel Barrot said it was important to “have a good agreement” and suggested there should be no rush for an agreement at any cost.
“Many important points still need to be covered in a single night,” he added.
Concerns over AI’s impact and the need to supervise the technology are shared worldwide.
US President Joe Biden issued an executive order in October to regulate AI in a bid to mitigate the technology’s risks.
News
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
